FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023287155> ?p ?o ?g. }

• W2023287155 endingPage "4905" @default.
• W2023287155 startingPage "4900" @default.
• W2023287155 abstract "Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) is a tumor necrosis factor superfamily member that induces apoptosis through the death receptors DR4 and/or DR5 in various cancer cell types but not in most normal cells. Several lung cancer cell lines express DR4 and DR5 and undergo apoptosis in vitro in response to Apo2L/TRAIL. We investigated the efficacy of recombinant soluble human Apo2L/TRAIL and its interaction with chemotherapy in xenograft models based on human NCI-H460 non-small cell lung carcinoma cells. In vitro, Taxol enhanced caspase activation and apoptosis induction by Apo2L/TRAIL. In vivo, Apo2L/TRAIL or Taxol plus carboplatin chemotherapy partially delayed progression of established subcutaneous tumor xenografts, whereas combined treatment caused tumor regression and a substantially longer growth delay. Apo2L/TRAIL, chemotherapy, or the combination of both inhibited growth of preformed orthotopic lung parenchymal tumors versus control by 60%, 57%, or 97%, respectively (all P < 0.01; n = 8-10). Furthermore, combination treatment improved day-90 survival relative to control (7 of 15 versus 1 of 15; P = 0.0003 by Mantel-Cox) as well as to Apo2L/TRAIL (3 of 14; P = 0.031) or chemotherapy (3 of 15; P = 0.035). These studies provide evidence for in vivo activity of Apo2L/TRAIL against lung tumor xenografts and underscore the potential of this ligand for advancing current lung cancer treatment strategies." @default.
• W2023287155 created "2016-06-24" @default.
• W2023287155 creator A5009606169 @default.
• W2023287155 creator A5009907074 @default.
• W2023287155 creator A5010583172 @default.
• W2023287155 creator A5028133447 @default.
• W2023287155 creator A5036233601 @default.
• W2023287155 creator A5053216437 @default.
• W2023287155 creator A5060319070 @default.
• W2023287155 creator A5069311189 @default.
• W2023287155 creator A5076471118 @default.
• W2023287155 creator A5077900421 @default.
• W2023287155 date "2004-07-15" @default.
• W2023287155 modified "2023-10-17" @default.
• W2023287155 title "Apo2 Ligand/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cooperates with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival" @default.
• W2023287155 cites W1484817497 @default.
• W2023287155 cites W1521538212 @default.
• W2023287155 cites W1978480779 @default.
• W2023287155 cites W1984709119 @default.
• W2023287155 cites W1986092295 @default.
• W2023287155 cites W1993129579 @default.
• W2023287155 cites W2007062088 @default.
• W2023287155 cites W2007681284 @default.
• W2023287155 cites W2009085926 @default.
• W2023287155 cites W2016417780 @default.
• W2023287155 cites W2032585979 @default.
• W2023287155 cites W2038118195 @default.
• W2023287155 cites W2044573147 @default.
• W2023287155 cites W2054717287 @default.
• W2023287155 cites W2056217426 @default.
• W2023287155 cites W2084733813 @default.
• W2023287155 cites W2088580558 @default.
• W2023287155 cites W2089082314 @default.
• W2023287155 cites W2089476060 @default.
• W2023287155 cites W2092508425 @default.
• W2023287155 cites W2105186639 @default.
• W2023287155 cites W2105441981 @default.
• W2023287155 cites W2106284224 @default.
• W2023287155 cites W2108307486 @default.
• W2023287155 cites W2113505777 @default.
• W2023287155 cites W2119326933 @default.
• W2023287155 cites W2130988210 @default.
• W2023287155 doi "https://doi.org/10.1158/0008-5472.can-04-0408" @default.
• W2023287155 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15256461" @default.
• W2023287155 hasPublicationYear "2004" @default.
• W2023287155 type Work @default.
• W2023287155 sameAs 2023287155 @default.
• W2023287155 citedByCount "101" @default.
• W2023287155 countsByYear W20232871552012 @default.
• W2023287155 countsByYear W20232871552013 @default.
• W2023287155 countsByYear W20232871552014 @default.
• W2023287155 countsByYear W20232871552015 @default.
• W2023287155 countsByYear W20232871552016 @default.
• W2023287155 countsByYear W20232871552018 @default.
• W2023287155 countsByYear W20232871552020 @default.
• W2023287155 countsByYear W20232871552022 @default.
• W2023287155 crossrefType "journal-article" @default.
• W2023287155 hasAuthorship W2023287155A5009606169 @default.
• W2023287155 hasAuthorship W2023287155A5009907074 @default.
• W2023287155 hasAuthorship W2023287155A5010583172 @default.
• W2023287155 hasAuthorship W2023287155A5028133447 @default.
• W2023287155 hasAuthorship W2023287155A5036233601 @default.
• W2023287155 hasAuthorship W2023287155A5053216437 @default.
• W2023287155 hasAuthorship W2023287155A5060319070 @default.
• W2023287155 hasAuthorship W2023287155A5069311189 @default.
• W2023287155 hasAuthorship W2023287155A5076471118 @default.
• W2023287155 hasAuthorship W2023287155A5077900421 @default.
• W2023287155 hasConcept C121608353 @default.
• W2023287155 hasConcept C126322002 @default.
• W2023287155 hasConcept C150903083 @default.
• W2023287155 hasConcept C17991360 @default.
• W2023287155 hasConcept C190283241 @default.
• W2023287155 hasConcept C203014093 @default.
• W2023287155 hasConcept C207001950 @default.
• W2023287155 hasConcept C2776256026 @default.
• W2023287155 hasConcept C2776694085 @default.
• W2023287155 hasConcept C2778239845 @default.
• W2023287155 hasConcept C2781451048 @default.
• W2023287155 hasConcept C502942594 @default.
• W2023287155 hasConcept C503630168 @default.
• W2023287155 hasConcept C55493867 @default.
• W2023287155 hasConcept C71924100 @default.
• W2023287155 hasConcept C86803240 @default.
• W2023287155 hasConceptScore W2023287155C121608353 @default.
• W2023287155 hasConceptScore W2023287155C126322002 @default.
• W2023287155 hasConceptScore W2023287155C150903083 @default.
• W2023287155 hasConceptScore W2023287155C17991360 @default.
• W2023287155 hasConceptScore W2023287155C190283241 @default.
• W2023287155 hasConceptScore W2023287155C203014093 @default.
• W2023287155 hasConceptScore W2023287155C207001950 @default.
• W2023287155 hasConceptScore W2023287155C2776256026 @default.
• W2023287155 hasConceptScore W2023287155C2776694085 @default.
• W2023287155 hasConceptScore W2023287155C2778239845 @default.
• W2023287155 hasConceptScore W2023287155C2781451048 @default.
• W2023287155 hasConceptScore W2023287155C502942594 @default.
• W2023287155 hasConceptScore W2023287155C503630168 @default.
• W2023287155 hasConceptScore W2023287155C55493867 @default.
• W2023287155 hasConceptScore W2023287155C71924100 @default.

• next